Navigation Links
MED3OOO Appoints Angela Hoffman as Chief Compliance Officer
Date:10/7/2008

PITTSBURGH, Oct. 7 /PRNewswire/ -- MED3OOO Group, Inc. (MED3OOO), a national leader in healthcare management and technology products and services for providers and employers, recently appointed Angela Hoffman to the position of Chief Compliance and Ethics Officer. Ms. Hoffman has 29 years of experience in healthcare which includes over 10 years in healthcare compliance and risk management.

In this role, Ms. Hoffman will be responsible for the oversight of MED3OOO's corporate compliance and ethics program, as well as compliance oversight for MED3OOO's existing operating units in the U.S. and newly developed operating units outside the U.S.

"MED3OOO is now one of the largest and most advanced providers of Healthcare Management, Revenue Cycle Management, and Technology services to physicians in the U.S.," noted Patrick V. Hampson, Chairman and CEO of MED3OOO. "We believe that compliance and business ethics are paramount in our company-wide culture and operations. The appointment of Angela Hoffman to our existing team of compliance experts is an additional investment in our commitment to our clients, employees, and shareholders."

Prior to joining MED3OOO, Ms. Hoffman served as both the Director of Compliance for the Corporate Ethics and Compliance Office and the Director of the HIPAA Program Office at the University of Pittsburgh Medical Center (UPMC), which employs 50,000 physicians and other personnel in its U.S. and international operations. She also served as the Manager of Regulatory Reporting for the University of Pittsburgh Physicians Compliance Office. Ms. Hoffman began her career in Nursing and held various Nursing Management positions at Allegheny General Hospital and UPMC Presbyterian Shadyside, which are both large tertiary care facilities in Pittsburgh, PA. Ms. Hoffman has also served as adjunct faculty at the Community College of Allegheny County as a Clinical Instructor and has experience in a variety of clinical specialties. Ms. Hoffman earned a BSN and MSN with a concentration in Health Care Management from La Roche College in Pittsburgh, PA.

Photo of Angela Hoffman: http://www.ereleases.com/pr/2008-MED3OOO.jpg

About MED3OOO

(Logo: http://www.ereleases.com/pr/MED3OOO_logo.jpg )

MED3OOO, a leader in healthcare management services, information management, and technologies, advances the quality and performance of healthcare delivery for providers and payors across the United States. Focused on the provision of evidence-based management and population health management, MED3OOO empowers over 15,000 physician, hospital, employer, health system, and municipal clients across the United States. For more information, please visit http://www.MED3000.com or contact Karla Sartori, MED3OOO Corporate Marketing, at 412-937-8887 or Karla_Sartori@MED3000.com.

CONTACT:

Karla Sartori

412-937-8887 ext. 325

Karla_Sartori@MED3000.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE MED3OOO, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MED3OOO Client Wins IHA Pay-for-Performance Award
2. Molina Medical Group Selects MED3OOO
3. PSA, LLC, a MED3OOO Company, Selected as a Member of the SC Provider Outreach and Education Advisory Group
4. MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement
5. WorldHeart Appoints David Pellone Chief Financial Officer
6. Novo Nordisk Appoints New Leader of North American Business
7. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
8. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
9. Resonant Medical Appoints New Vice President of Global Sales
10. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
11. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... Gevir, a New ... antler velvet, announced its products are coming soon to Amazon.com, the world’s largest online ... Thomson as a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... treatment to the thousands of individuals who have recently fallen victim to America’s opioid ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology: